Chronic Lymphoblastic Leukemia


Treanda® and Rituxan® Effective for Relapsed CLL (12-11-2008)

Treanda® and Rituxan® Effective for Relapsed CLL In a Phase II clinical trial, the combination of Treanda® (bendamustine)®and Rituxan® (rituximab)®produced promising results among patients with relapsed chronic lymphocytic leukemia (CLL). These... Continue Reading